We are thrilled to share that Nicole Desloges, our Senior Vice President of People, has been selected as an Excellence Awardee in the annual Canadian HR Awards! This recognition is… Read More
The Stem Cell Network (SCN) is pleased to announce the first of two national research funding competitions planned for SCN’s 2025-2029 funding cycle. This new competition will support world-class, translational,… Read More
TORONTO, ON – The National Advisory Committee on Immunization’s (NACI) annual Statement on Seasonal Influenza Vaccines for 2024-2025 continues to recommend Fluzone® High-Dose Quadrivalent among the preferential influenza vaccines, over standard dose… Read More
The marketing authorization for SKYRIZI® (risankizumab) marks its fourth approved indication in the European Union The approval is supported by data from two pivotal Phase 3 trials: The INSPIRE induction trial1 and… Read More
VANCOUVER, BC – Augurex Life Sciences Corp. is pleased to announce that it will be presenting two posters at the upcoming Association for Diagnostic & Laboratory Medicine (ADLM 2024) in… Read More
